Twist Bioscience to Present at the 37th Annual J.P. Morgan Healthcare Conference
January 02 2019 - 8:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA, today announced that Emily Leproust, Ph.D., CEO and
co-founder, will present at the 37th Annual J.P. Morgan Healthcare
Conference on Wednesday, January 9th at 1:30 p.m. Pacific Time in
San Francisco.
This presentation will be webcast live and can be accessed by
visiting the “Presentations” page of the investor relations section
of the company's website here. A replay of the presentation will be
archived for a period of 90 days following the conclusion of the
live event.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology company that has developed a disruptive DNA synthesis
platform to industrialize the engineering of biology. The core of
the platform is a proprietary technology that pioneers a new method
of manufacturing synthetic DNA by “writing” DNA on a silicon chip.
Twist is leveraging its unique technology to manufacture a broad
range of synthetic DNA-based products, including synthetic genes,
tools for next-generation sequencing (NGS) preparation, and
antibody libraries for drug discovery and development. Twist is
also pursuing longer-term opportunities in digital data storage in
DNA and biologics drug discovery. Twist makes products for use
across many industries including healthcare, industrial chemicals,
agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190102005162/en/
Investor Contact:Argot PartnersMaeve
Conneighton212-600-1902maeve@argotpartners.com
Media Contact:Angela Bitting925-
202-6211media@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Apr 2024 to May 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From May 2023 to May 2024